Article de revue
The doses of 10 μg should replace the doses of 5 μg in newborn hepatitis B vaccination in China: A cost-effectiveness analysis
For newborn hepatitis B vaccination in China, the 10 μg strategy should be cost-effective, even more possibly highly cost-effective or cost-saving compared with the current 5 μg strategy. The doses of 10 μg should be considered to replace the doses of 5 μg in newborn hepatitis B vaccination in China.
Auteurs
Langues
- Anglais
Année de publication
2015
Journal
Vaccine
Volume
31
Type
Article de revue
Catégories
- Gestion de programme
Maladies
- Hépatite B
Pays
- Chine
Mots-clés
- Introduction de nouveaux vaccins
- Planification, budgétisation et financement
Régions de l'OMS
- Région du Pacifique occidental